Tootsie Roll posted FY 2025 net product sales of USD 724.7 million (+1.3%) and operating earnings of USD 100.9 million. FY 2025 net earnings attributable to shareholders were USD 100.1 million, with EPS of USD 1.37 (+16.1%). In Q4 2025, net product sales were USD 194.4 million (+1.6%), net earnings attributable to shareholders were USD 28.8 million, and EPS was USD 0.40 (+29.0%). Other income, net in FY 2025 was USD 36.3 million (+37.7%), including USD 20.2 million of investment income from available-for-sale securities, while the effective income tax rate was 27.1% in FY 2025 and 27.1% in Q4 2025. The company said FY 2025 sales gains were driven primarily by price increases and marketing and sales programs, while noting increased consumer resistance to higher prices. It also highlighted continued cocoa and chocolate cost increases in 2025, with lower cocoa and chocolate costs expected to be realized in late 2026 and into 2027 as lower commodity prices flow through the supply chain. Tootsie Roll estimated incremental tariff costs of approximately USD 3.7 million in FY 2025 and said tariffs on cocoa were rescinded in Q4 2025, which it expects to support cost reductions in 2026. The company reported a 2025 operating loss of USD 2.2 million at its Spanish subsidiary and said it expects operating losses there to continue in 2026 and likely require additional cash financing.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tootsie Roll Industries Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-021621), on February 27, 2026, and is solely responsible for the information contained therein.
Comments